Literature DB >> 3802503

Laser immunonephelometry for routine quantification of urinary albumin excretion.

M Marre, J P Claudel, P Ciret, N Luis, L Suarez, P Passa.   

Abstract

We describe a laser-immunonephelometric method for quantifying urinary albumin excretion (UAE) in large numbers of samples. For a 150-microL sample incubated at room temperature for 45 min with 40 microL of antiserum specific for human serum albumin, the assay range for albumin was 0.34 to 43.0 mg/L. For samples analyzed undiluted and diluted 10-fold, the range of measurable albumin was from 0.34 to 430.0 mg/L. With an automated version of this method, one can assay 240 samples per hour. Intra- and interassay CVs were less than 6% and 9%, respectively. Measurements by this method (y) correlated well with those obtained by a RIA method (x): y = 1.00x + 0.163 mg/L (n = 233; r = 0.996). The day-to-day CV for UAE was determined for three consecutive determinations done on each of 60 controls according to the time of collection and in 212 diabetics according to the amount of 24-h UAE. For controls, UAE was 8.0 +/- 8.1 mg/24 h (mean +/- SD), CV 44 +/- 23%. The CV was similar for diurnal (50 +/- 28%) and overnight (58 +/- 32%) collections from controls; and for diabetics with normal values for UAE: 35 +/- 32%, with slight albuminuria (25-300 mg/24 h):37 +/- 28%, or with macroalbuminuria (greater than 300 mg/24 h): 47 +/- 42%.

Entities:  

Mesh:

Year:  1987        PMID: 3802503

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  First morning voids are more reliable than spot urine samples to assess microalbuminuria.

Authors:  Elsbeth C Witte; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Paul E de Jong; Ronald Gansevoort
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

2.  Serum lipids and urinary albumin excretion in non insulin-dependent diabetics.

Authors:  S Suraniti; F Bled; A Girault; P Fressinaud; M Marre
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

3.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

Authors:  M Marre; X Jeunemaitre; Y Gallois; M Rodier; G Chatellier; C Sert; L Dusselier; Z Kahal; L Chaillous; S Halimi; A Muller; H Sackmann; B Bauduceau; F Bled; P Passa; F Alhenc-Gelas
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.

Authors:  S Hadjadj; R Aubert; F Fumeron; F Pean; J Tichet; R Roussel; M Marre
Journal:  Diabetologia       Date:  2005-05-05       Impact factor: 10.122

5.  Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.

Authors:  M Hallab; Y Gallois; G Chatellier; V Rohmer; P Fressinaud; M Marre
Journal:  BMJ       Date:  1993-01-16

6.  Urinary zinc and its relationships with microalbuminuria in type I diabetics.

Authors:  J F Brun; C Fons; M Fussellier; L Bardet; A Orsetti
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

7.  Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.

Authors:  A López; J Hinojosa; A Miralles; J Primo; J D Bermúdez
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

8.  Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study.

Authors:  N S Shcherbak
Journal:  BMC Med Genet       Date:  2001-07-24       Impact factor: 2.103

9.  Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.

Authors:  Gilberto Velho; Nadine Bouby; Samy Hadjadj; Nadia Matallah; Kamel Mohammedi; Frédéric Fumeron; Louis Potier; Naïma Bellili-Munoz; Christopher Taveau; François Alhenc-Gelas; Lise Bankir; Michel Marre; Ronan Roussel
Journal:  Diabetes Care       Date:  2013-07-17       Impact factor: 19.112

10.  Moving Toward Standardization of Urine Albumin Measurements.

Authors:  Jesse C Seegmiller; W Greg Miller; Lorin M Bachmann
Journal:  EJIFCC       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.